Navigation Links
Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial
Date:5/8/2008

in the United States): the TRIUMPH(TM) Posterolateral Disc, the TRANSITION(TM) Posterior Dynamic Stabilization System, and the FLEXUS(TM) Inspinous Process Spacer System are among the numerous research posters and presentations concerning the Company's products at this week's Spine Arthroplasty Society (SAS) meeting in Miami, Florida.

About Globus Medical, Inc.

Globus Medical, Inc. the largest privately held spinal implant manufacturer in the world is based in Audubon, PA. The privately held company was founded in 2003 by an experienced team of spine professionals with a shared vision to create products that enable spine surgeons to employ both fusion and non-fusion solutions to promote healing in patients with spinal disorders. Globus Medical has a full portfolio of spinal fusion products, burgeoning initiatives in biomaterials development and minimally invasive approaches, and is among the world leaders in the development of motion preservation technology. Additional information can be accessed at http://www.globusmedical.com.


'/>"/>
SOURCE Globus Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Globus Medical Raises $110 Million in Series E Financing Round
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2008)...SAN DIEGO, May 9 /- Ardea B...ed on the discovery and development of,small- mole... and,inflammatory diseases, including gout, today ...ior Vice President, Finance and Operations and Chi...ll resign from our board of,directors shortly ther...
(Date:5/9/2008)...Fifth International Phase III Study Shows Positive... Data -, NUTLEY, N.J., May 9 /- Roc...-year Phase III study showing that ACTEMRA(TM),(to...f structural damage to,joints in patients with rhe...ctiveness of an RA treatment. The study also demon...
(Date:5/8/2008)...CLEVELAND, May 8 /- DATATRA...gy and services company focused on global,eClinica...y reported its,operating results for the first qua...1, 2008, revenue decreased,approximately 41% to $2...2,233,000), or $(0.16) per share on both a basic a...
(Date:5/8/2008)...BOSTON, May 8 /- The Cancer Research ...ation,s top cancer centers, is asking,303 million ...onating $1 to,cancer research efforts this Mother,... the "Infinite Power of One(TM)" has two key goals... into their own hands by,joining together to exerc...
Breaking Medicine Technology:Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 3New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 5DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 2World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 3World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 4World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 5Tobacco marketers targeting teens near schools 7022 1Tobacco marketers targeting teens near schools 7022 2Combo PET CT Scan Helps Spot Breast Cancers Spread 7019 1Combo PET CT Scan Helps Spot Breast Cancers Spread 7019 2Combo PET CT Scan Helps Spot Breast Cancers Spread 7019 3Nastech to Present at BMO Capital Markets Focus on Healthcare Conference 1967 1Studies suggest HIV subtype more deadly than others 7015 1Studies suggest HIV subtype more deadly than others 7015 2
...le and Excellent,Pharmacokinetic Properties -, RES...ire/ --,CeNeRx BioPharma, Inc., a clinical stage c...reatments for diseases of the central,nervous syst...I,clinical trial of Tyrima(TM), its lead candidate...his study, Tyrima was safe and well,tolerated. Tyr...
...rstCall/ - Oncolytics,Biotech Inc. announced today...reovirus in combination with gemcitabine is availa...esearch (AACR),website at <a target="_blank" href=...Oncolytics,website at <a target="_blank" href=,"ht...tech.com .,The abstract is entitled "In Vivo Syner...
Other Medicine Technology:CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 3Oncolytics Biotech Inc. Collaborators to Present,Reovirus/Gemcitabine Combination Research at AACR Annual Meeting 2Oncolytics Biotech Inc. Collaborators to Present,Reovirus/Gemcitabine Combination Research at AACR Annual Meeting 3
(Date:5/13/2008)...njecting healthy gene into brain slowed Batten dis...) -- A new gene therapy that involves injecting a ...afe and effective way to slow Batten disease, a ra...l between the ages of 8 and 12. , Children with...l Ceroid Lipofuscinosis, are born with a mutated C...
(Date:5/13/2008)...re/ -- It was a sellout for Actifirm(R), a,leading...ural botanicals,in its first hour-long show on QV...ett and Actifirm president Elysiann Bishop,present... Face Firm(TM);,Renovation Cream; Renovation Eye C...very kit with Actifirm products for cleansing, exf...
(Date:5/13/2008)...May 13 /PRNewswire/ -- Stater Bros. is pleased,to ...yees recently raised,$501,707 to benefit the Ameri...om.com/cgi-bin/prnh/20080513/LATU098 ), (Logo: h...LOGO ), Since 2002, Stater Bros. has raised over ...uring the month of February 2008, Stater Bros. cus...
(Date:5/13/2008)...32 Nurses Negotiating With Genesys Regional,Medica...wswire/ -- Teamsters General,President Jim Hoffa a...,Wednesday, May 14, 2008, to show community suppor... negotiations with Genesys Regional Medical,Center...e-to-patient ratios and to,continue quality, affor...
Breaking Medicine News(10 mins):Health News:Therapy Yields Promise for Fatal Neurological Condition 2Health News:Actifirm Sells Out in First Hour Appearance on QVC 2Health News:Stater Bros. Raises $501,707 for American Heart Association 2
...rbidden Fruit. If you think it’s porn, you are wr...or safe sex//. Gujarat medico Gaurav Chhabra's 80...t the mobiles soon, a fictional clip spreading awa...ing people on the disease while urging them to hav...
...nization in the next ten years to save an addition...s reaching more children with basic vaccines, impr...ines such as those for pneumococcus, rotavirus, me...litis, a UNICEF and WHO report released here revea...
...l guidance it has been proposed that overweight, s...eatment on the NHS//. This comes from a government... National Institute for Health and Clinical Excell... should avoid discriminating against patients with...
...ire higher doses of Tamiflu, than what Roche Holdi...nging to the World Health //Organization (WHO). If...f the symptoms, then the duration and severity of ...is being stockpiled across the world to treat the ...
Other Medicine News:Health News:This MMS Educates, And Not Titillates 2Health News:$35 billion needed globally for immunization 2Health News:$35 billion needed globally for immunization 3Health News:Dosage Of Tamiflu Sought To Be Increased 2
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
Medicine Products: